SUBSCRIBE
|
FAQs
Home
About Us
Who we are
the sahpra board
EXECUTIVE MANAGEMENT
Regulatory Partnerships
SPECIAL PROJECTS
Backlog
Vacancies
Health Products
Human Medicines
ORTHODOX MEDICINES
Biological Products
Complementary Medicines
Medical Devices
Radiation Control
Unregistered Products
Veterinary Medicines
News
Latest News & Updates
Press Releases
Presentations
Social Media
WORKSHOPS AND CONFERENCES
Upcoming Events
Online Services
Product Variations Portal
Complementary Medicines Licensing
COVI-VIG Reporting System
Health Product Application Status Checker
Access to Unregistered Health Products
New Authorizations
Re-Authorizations
Adverse Drug Reaction Reporting
PUBLICATIONS
Acts and regulations
GOVERNMENT GAZETTES AND REGULATIONS
SAHPRA Planning Documents
FEES
Guidelines
Newsletters
Annual Report
tenders
Corporate Identity
Contact us
Head office
key contacts
media enquiries
FEEDBACK TO SAHPRA
Home
About Us
Who we are
the sahpra board
EXECUTIVE MANAGEMENT
Regulatory Partnerships
SPECIAL PROJECTS
Backlog
Vacancies
Health Products
Human Medicines
ORTHODOX MEDICINES
Biological Products
Complementary Medicines
Medical Devices
Radiation Control
Unregistered Products
Veterinary Medicines
News
Latest News & Updates
Press Releases
Presentations
Social Media
WORKSHOPS AND CONFERENCES
Upcoming Events
Online Services
Product Variations Portal
Complementary Medicines Licensing
COVI-VIG Reporting System
Health Product Application Status Checker
Access to Unregistered Health Products
New Authorizations
Re-Authorizations
Adverse Drug Reaction Reporting
PUBLICATIONS
Acts and regulations
GOVERNMENT GAZETTES AND REGULATIONS
SAHPRA Planning Documents
FEES
Guidelines
Newsletters
Annual Report
tenders
Corporate Identity
Contact us
Head office
key contacts
media enquiries
FEEDBACK TO SAHPRA
October 2019
Safety Alerts
MSA promethazine
October 25, 2019
Safety Alerts
Uncategorized
MSA ketoconazole and domperidone
October 25, 2019
Safety Alerts
MSA gamma benzine hexachloride
October 25, 2019
Safety Alerts
MSA cough and cold medicines
October 25, 2019
Safety Alerts
MSA atypical antipsychotics
October 25, 2019
Safety Alerts
DHCPL for ACE-inhibitor/Angiotensin receptor blocker containing medicines
October 25, 2019
Presentations
The Status of Cannabis for Medicinal and Research Purposes
October 25, 2019
Presentations
SAHPRA – APP – PRESENTATION TO PORTFOLIO COMMITTEE
October 25, 2019
Presentations
SAHPRA BACKLOG CLEARANCE PROGRAM GO LIVE
October 25, 2019
Presentations
SAHPRA BACKLOG CLEARANCE PROGRAM – PRESENTATION FOR MEDIA BRIEFING – VFOR REVIEW
October 25, 2019
1
2
3
